By Stephen Nakrosis
Shares of Nutex Health climbed following fourth-quarter results that topped analysts' estimates, including a significant increase in revenue.
Fourth-quarter revenue more than tripled to $257.6 million from $69.7 million a year ago. Analysts were expecting revenue of $81.1 million.
The healthcare-management and operations company said it believes its arbitration efforts, through the independent dispute resolution process, resulted in more equitable payments.
The stock was up 41%, to $66.51 a share, in after-hours trading Monday, after closing the regular session down 9%, at $47.03. Shares at one point reached $72.00 apiece in post-market trading, topping the 52-week high of $69.45 set on Feb. 14.
The Houston company reported net income for the fourth quarter of $61.7 million, and earnings per share of $11.12, compared with a loss of $31.6 million, for a loss of $7.47 per share, in the same period a year earlier.
Analysts expected a fourth-quarter loss of $600,000, or 12 cents a share, according to a survey by FactSet.
Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
(END) Dow Jones Newswires
March 31, 2025 19:23 ET (23:23 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.